Your email has been successfully added to our mailing list.

×
-0.0183206106870229 -0.00763358778625954 -0.0236641221374045 -0.0122137404580152 -0.00458015267175568 0.0167938931297711 0.0149007633587786 0.00763358778625954
Stock impact report

FDA OKs Intersect ENT's Sinuva sinus implant; shares up 17% [Seeking Alpha]

Intersect ENT, Inc. (XENT) 
Last intersect ent, inc. earnings: 2/24 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intersectent.com/investor-relations
Company Research Source: Seeking Alpha
FDA OKs Intersect ENT's Sinuva sinus implant; shares up 17%Thinly traded Intersect ENT (XENT+16.8%) is up on modestly volume, albeit on turnover of only 168K shares, in response to itsannouncement that the FDA has approved the SINUVA (mometasone furoate) Sinus Implant for treating recurrent nasal polyps in patients who have had previous ethmoid sinus surgery.SINUVA, a device that delivers an anti-inflammatory steroid directly to the site of polyps, can be placed by a physician in an office setting.The FDA's action was January 7, 2018.See all stocks on the move » Show less Read more
Impact Snapshot
Event Time:
XENT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for XENT alerts
Opt-in for
XENT alerts

from News Quantified
Opt-in for
XENT alerts

from News Quantified